Regulation
First patient treated in FDA IDE study of Aqua Medical’s PIMA device
Aqua Medical has enrolled the first West Coast patient in RESTORE-I, an FDA-approved investigational device exemption (IDE) study evaluating its PIMA procedure for type 2 diabetes treatment in adults. The trial represents advancement of the device through the FDA's clinical investigation pathway.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network